These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 37494097

  • 1. Co-Constructing a Community-Based Telemedicine Program for People With Opioid Use Disorder During the COVID-19 Pandemic: Lessons Learned and Implications for Future Service Delivery.
    Høj SB, de Montigny C, Chougar S, Léandre R, Beauchemin-Nadeau MÈ, Boyer-Legault G, Goyette A, Lamont SK, Bruneau J.
    JMIR Public Health Surveill; 2023 Jul 26; 9():e39236. PubMed ID: 37494097
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Implementation of a medical student-run telemedicine program for medications for opioid use disorder during the COVID-19 pandemic.
    Castillo M, Conte B, Hinkes S, Mathew M, Na CJ, Norindr A, Serota DP, Forrest DW, Deshpande AR, Bartholomew TS, Tookes HE.
    Harm Reduct J; 2020 Nov 17; 17(1):88. PubMed ID: 33203460
    [Abstract] [Full Text] [Related]

  • 5. Implementing a low-threshold audio-only telehealth model for medication-assisted treatment of opioid use disorder at a community-based non-profit organization in Washington, D.C.
    Yeo EJ, Kralles H, Sternberg D, McCullough D, Nadanasabesan A, Mayo R, Akselrod H, Catalanotti J.
    Harm Reduct J; 2021 Dec 09; 18(1):127. PubMed ID: 34886850
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Care Integration for Hepatitis C Virus Treatment Through Facilitated Telemedicine Within Opioid Treatment Programs: Qualitative Study.
    Dickerson SS, George SJ, Ventuneac A, Dharia A, Talal AH.
    J Med Internet Res; 2024 Jun 12; 26():e53049. PubMed ID: 38865703
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
    Weintraub E, Seneviratne C, Anane J, Coble K, Magidson J, Kattakuzhy S, Greenblatt A, Welsh C, Pappas A, Ross TL, Belcher AM.
    JAMA Netw Open; 2021 Aug 02; 4(8):e2118487. PubMed ID: 34448869
    [Abstract] [Full Text] [Related]

  • 18. Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study.
    Oviedo-Joekes E, MacDonald S, Boissonneault C, Harper K.
    Subst Abuse Treat Prev Policy; 2021 Mar 05; 16(1):22. PubMed ID: 33673847
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Improving equity and access to buprenorphine treatment through telemedicine at syringe services programs.
    Lambdin BH, Kan D, Kral AH.
    Subst Abuse Treat Prev Policy; 2022 Jul 15; 17(1):51. PubMed ID: 35841036
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.